Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.
about
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis ControlFailed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to manGenetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary studyResearch for new drugs for elimination of onchocerciasis in AfricaLoa loa ecology in central Africa: role of the Congo River systemEosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas.Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in CameroonImpact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.Characteristics of persons who complied with and failed to comply with annual ivermectin treatment.A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa
P2860
Q24800816-4599F854-D692-47D4-8D98-D767F0FA1797Q24800981-7989483A-07CC-44CF-908C-BA0697B159AAQ24804532-567600E1-08F6-43CC-AA77-4B27CB2F82D9Q28066402-B354F94E-6AD5-4F8F-8261-70FA97814638Q34321712-E0A3A471-D140-4392-984D-300F8B026CFEQ34974564-19D9B920-CDC4-4526-BBE6-F04F100F16EAQ35372570-9F7869E8-EF99-4B19-9664-4C9163BBA017Q36286101-96CDA8AB-0E58-47E1-8D2D-C387FEDC7CBFQ36417053-87164E36-08A2-4953-B8F2-267E7C3E388BQ37362005-1A6E29CF-48B3-4C04-A896-94E48F194912Q38867971-48F79844-0B0B-4A4D-AC86-99AE91ACF96DQ46372145-36732F5D-AC67-4EBC-8BFE-1731C52BCEF2Q58723511-9F16FA43-AF65-42D3-8DEB-0E15D8B63A49
P2860
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@ast
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@en
type
label
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@ast
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@en
prefLabel
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@ast
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@en
P2093
P2860
P1433
P1476
Programmatic and Communication ...... or Onchocerciasis and Loiasis.
@en
P2093
Cyrille Evini
Julie Akame
Nancy J Haselow
Serge Akongo
P2860
P2888
P356
10.1186/1475-2883-2-S1-S10
P478
P577
2003-01-01T00:00:00Z
P6179
1002288582